New pharmacological treatments for opioid dependence include detoxific
ation agents such as clonidine and lofexidine, and maintenance agents
such as levacetylmethadol (levo-alpha-acetylmethadol; LAAM) and bupren
orphine. Detoxification from opioids has been facilitated by the devel
opment of clonidine, particularly in combination with naltrexone. New
experimental approaches have also been tried to reduce the time that i
t takes to complete the process of detoxification or to further reduce
residual withdrawal symptoms not completely relieved by clonidine. Ma
intenance on levacetylmethadol or buprenorphine has become a viable al
ternative to methadone maintenance and holds promise for the future.